TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
53.31
-0.21 (-0.39%)
At close: Jul 2, 2026, 4:00 PM EDT
53.35
+0.04 (0.08%)
After-hours: Jul 2, 2026, 7:49 PM EDT
TG Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, TG Therapeutics stock has a consensus rating of "Buy" and an average price target of $51.71. The average 1-year stock price forecast is 3.00% lower than the current stock price, while the lowest is $17 (-68.11%) and the highest is $83 (+55.69%).
Price Target: $51.71 (-3.00%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TG Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Reiterates $57 → $83 | Buy | Reiterates | $57 → $83 | +55.69% | Jun 22, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $70 | Buy | Maintains | $70 | +31.31% | Jun 9, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains $17 | Sell | Maintains | $17 | -68.11% | Jun 4, 2026 |
Unknown Analyst B. Riley Securities No rating | B. Riley Securities | Buy Reiterates $55 | Buy | Reiterates | $55 | +3.17% | Jun 4, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $41 | Hold | Maintains | $41 | -23.09% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
941.40M
from 616.29M
Increased by 52.75%
Revenue Next Year
1.23B
from 941.40M
Increased by 30.42%
EPS This Year
1.54
from 2.77
Decreased by -44.58%
EPS Next Year
2.87
from 1.54
Increased by 87.09%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 966.5M | ||
| Avg | 941.4M | ||
| Low | 923.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 56.8% | ||
| Avg | 52.8% | ||
| Low | 49.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.67 | ||
| Avg | 1.54 | ||
| Low | 1.30 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -39.7% | ||
| Avg | -44.6% | ||
| Low | -53.1% |